To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Injection of Mesenchymal Stromal Cells During Knee Arthroscopy Improves 1-Year Clinical Outcomes

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2021

Injection of Mesenchymal Stromal Cells During Knee Arthroscopy Improves 1-Year Clinical Outcomes

Vol: 10| Issue: 2| Number:26| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The clinical efficacy of arthroscopic therapy with knee infrapatellar fat pad cell concentrates in treating knee cartilage lesion: a prospective, randomized, and controlled study

J Orthop Surg Res. 2021 Jan 28;16(1):87.

Contributing Authors:
Y Zhou H Li D Xiang J Shao Q Fu Y Han J Zhu Y Chen Q Qian

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty patients with knee cartilage lesions were randomized to receive knee arthroscopic therapy with an injection of mesenchymal stromal cell concentrates source from the infrapatellar fat pad (n=30) or saline (n=30) into the joint cavity. The outcomes of interest included pain at rest and during motion on a Visual Analogue Scale (VAS), the Western Ontario and McMaster Universities Osteoarthritis ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue